Background and objectives The effectiveness of targeted screening for identification of CKD is largely unknown. The See Kidney Disease (SeeKD) targeted screening project aimed to determine the prevalence of unrecognized CKD in Canada.
Introduction
CKD, defined as eGFR,60 ml/min per 1.73 m 2 , is an important public health problem with increasing prevalence worldwide (1) (2) (3) . An estimated 2.9 million Canadian adults (4) , and up to 22% of individuals aged .70 years, have CKD (5) . Further, CKD increases the risk of cardiovascular disease and premature all-cause mortality (6) . Clinical practice guidelines recommend early recognition of CKD (7, 8) to enable implementation of interventions that can reduce morbidity and premature mortality (9) . However, there is a paucity of evidence to inform the optimal strategy for early recognition of CKD.
Population-based screening for CKD has not been shown to be cost-effective; however, targeted screening of people with diabetes (10) and hypertension (11) has been shown to have a similar cost per quality adjusted life year gained as other publicly funded health care initiatives. Targeted screening is directed at individuals with an increased risk of CKD, such as individuals with diabetes, hypertension, clinically relevant cardiovascular disease, family history of kidney failure, or aged $60 years (8) .
In the United States, the Kidney Early Evaluation Program (KEEP) screening program targeted populations at risk of CKD, and reported a prevalence of undiagnosed CKD of 28.7% (12) . In Canada, the See Kidney Disease (SeeKD) Targeted Screening program was conducted by The Kidney Foundation of Canada and its branches (regionalized locations) to identify unrecognized CKD and promote kidney health and disease prevention strategies. In this paper, we report the prevalence of unrecognized CKD from the SeeKD program, and describe the targeted screening strategies used.
Materials and Methods

Overview of the SeeKD Screening Program
Eight Kidney Foundation of Canada branches, spanning ten provinces, participated in the SeeKD screening program using a standardized protocol. Branches chose the location and target population for their screening events based on community characteristics. Branches were encouraged to hold screening events in locations where those at risk of CKD would be greatest using a convenience sample approach, participant accessibility was adequate, and with a publicly accessible venue provided free of cost. At least one registered nurse or pharmacist attended each screening event, and used predefined guidelines for medical follow-up of patients, if necessary.
Eligible participants were adults aged $18 years who provided informed consent and were eligible to participate in one screening event. The screening event used a standardized 3-step protocol to ensure only those at risk of CKD would receive kidney-specific testing (Supplemental Appendix 1). In step 1, participants completed a health data form to determine baseline sociodemographic characteristics, risk factors for CKD, knowledge of kidney disease and its risk factors, and current health behaviors. CKD risk was defined as at least one of the following self-reported risk factors: diagnosed diabetes, diagnosed high BP, existing kidney problems, family history of kidney disease, member of high-risk ethnic population (Aboriginal, Hispanic, South Asian, Asian, or African descent), current vascular disease, and currently using tobacco products. Participants were not specifically asked if they had existing CKD, and therefore all participants with self-reported kidney problems, which may have included other conditions such as nephrolithiasis and infections, were included. Participants identified as at risk of CKD moved to step 2, where clinical measurements, including point-of-care creatinine testing (Stat Sensor) and urinalysis, were obtained. The StatSensor tool has demonstrated good sensitivity (96%) and moderate specificity (79%) for detecting CKD, and has been suggested for use in screening of CKD (13) (14) (15) (16) . However, the single random urine dipstick measurement does not capture albuminuria, and thus CKD was defined using a single creatinine measurement. Participants with no evidence of risk factors for CKD were provided with information about kidney health and self-management approaches to prevent kidney disease. GFR was estimated using a creatinine measure and the CKD-Epidemiology Collaboration equation (17) . Finally, step 3 included a follow-up health survey sent to participants at risk of CKD within 2-4 weeks after attending the event (results reported separately). Of note, unrecognized CKD was defined as an eGFR,60 ml/min per 1.73 m 2 and where the patient is unaware of a current diagnosis of CKD, though one may have been made by their primary care physician.
Information Obtained to Characterize Screening Events
To further characterize the SeeKD screening events we contacted the Kidney Foundation of Canada branches after the screening events were completed (between July 2014 and September 2014), to obtain additional detailed information. Telephone interviews were scheduled with the person in charge of the event at each branch, or their delegate. The semistructured interviews, which ranged from 30 to 60 minutes, obtained information about the population of interest for screening, methods of advertising, location of the screening events, screening criteria and registration, resources utilized, length of events, and approximate number of participants screened per event.
Interviews were done by one member of the research team.
Based on this information we categorized the SeeKD events post hoc into two broad screening strategies: individual-targeted screening (defined as targeting individuals at high risk of CKD) and community-targeted screening (defined as an event in a community location in proximity to a high-risk population). The focus of events as individual-targeted or community-targeted was largely dependent upon available resources, as well as opportunities and relationships with communities at high risk of CKD.
Statistical Analyses
Descriptive statistics were used to characterize participants, including sociodemographics (age, sex), self-reported motivation to participate in screening, health knowledge of CKD, and risk factors for CKD, and were reported using numbers and proportions for binary and categorical variables, and means with SDs for continuous variables. Results were further stratified by screening strategy (individualtargeted and community-targeted).
Among individuals with self-reported risk factors for CKD who received point-of-care creatinine testing, we calculated the prevalence of unrecognized CKD, with 95% confidence intervals (95% CIs), overall, and by screening strategy and self-reported risk factors. Finally, we compared participants with unrecognized CKD to those with normal kidney function on sociodemographic data, risk factors for CKD, clinical characteristics (body mass index, urine protein, urine blood, random blood glucose, BP) and whether an individual required immediate medical attention at the screening event. Results were compared using Pearson chi-squared tests for proportions, the Wilcoxon rank sum test for multilevel categorical variables, and t tests for continuous variables. In a sensitivity analysis, we excluded participants that self-reported having kidney problems and had an eGFR,60 ml/min per 1.73 m 2 , to determine the prevalence of unrecognized CKD among participants without prior knowledge of kidney problems.
Qualitative descriptive methods were used to analyze and explore the variation in screening events collected through the interviews. Analysis was conducted by assigning codes to segments of the collected interview information, using a priori defined codes (categories). These segments of data were then organized in tabular format by category. Branches were invited to review and comment on the information to ensure accuracy.
The SeeKD targeted screening program received ethics approval from Health Canada as well as the Conjoint Health Research Ethics Board at the University of Calgary. All statistical analyses were conducted using Stata, version 11 (18) .
Results
Of the eight Kidney Foundation of Canada branches participating, one did not follow the standardized protocol and was removed from this analysis. As such, we report on the SeeKD program representing nine of the ten Canadian provinces. Of the seven participating branches of the Kidney Foundation of Canada, four conducted individual-targeted screening (screening events that specifically targeted individuals at risk of CKD and commonly had people sign up in advance of the screening event) ( Table 1) and three used a community-targeted screening strategy (held their screening events in public locations where highrisk individuals were expected, including those with limited health care access) ( Table 2) .
Description of Screening Events
Among branches that conducted individual-targeted screening, the individuals targeted were typically part of ethnic groups at increased risk of CKD or seniors, with events held in community centers or other gathering places, and advertised by the venue or community itself (Table 1) . Many events required sign-up prior to the event to ensure adequate resources were available and to avoid waiting lines for participants. Events were often repeated in the same venue to ensure that high-risk individuals had equal opportunity to participate. The number of participants screened also varied, as resources differed between screening events. Among branches that conducted community-targeted screening, events were held at a variety of locations, including grocery stores or community centers, and all were drop-in, with advertisements being optional and varied (Table 2) . Multiple events were often held in the same venue to foster relationships with communities. The number of participants screened varied, and was dependent on the number of people in the location on that specific day. Additional details and quotes from the qualitative interviews are provided in Supplemental Appendix 2.
Results of Screening Events
Overall, 6329 adults participated in the screening events, of whom 65.3% were female, with a mean age of 58.5 years (Table 3) . Of the 88.9% of participants who indicated at least one risk factor for CKD, the three most common were being a member of a high-risk ethnic population, a previous diagnosis of hypertension, or a previous diagnosis of diabetes (59.0%, 38.5%, and 22.4% respectively). Fifty percent of participants were motivated to participate because of a personal concern about their health, whereas 25.6% of participants identified the recruitment efforts by the branches as their motivation to participate. With regards to health knowledge, the majority of participants (84.9%) were able to identify at least one risk factor for CKD.
There were more participants recruited by individualtargeted events as compared with community-targeted (57.3% versus 42.8%, respectively). Individual-targeted also identified a higher proportion of participants with risk factors for CKD (92.4% versus 84.3%, respectively; P,0.001) ( Table 3 ). Though participant characteristics were similar by screening strategy, participants' motivation to participate in the screening events varied, with community-targeted events having a higher proportion of participants attending because of recruitment efforts (41.4% versus 13.9% for individual-targeted; P,0.001), while participants in the individual-targeted screening predominantly chose "concern for personal health status" (54.7% versus 43.9% for community-targeted; P,0.001).
Of the 5194 participants at risk of CKD who were screened, 50 people did not report their age and therefore eGFR could not be calculated (Figure 1 ). Among the 5144 participants with complete data, 18.8% (95% CI, 17.8 to 19.9) had unrecognized CKD, of whom 13.8% (95% CI, 12.9 to 14.7) had category 3a, 4.1% had category 3b, and ,1% had category 4 or 5 CKD (Table 4 ). The prevalence of unrecognized CKD was highest among those with the greatest number of CKD risk factors. The individual-targeted screening identified a higher proportion of participants with unrecognized CKD overall, when compared with community-targeted (21.9% versus 14.7%, respectively).
Compared with at-risk participants with no CKD, participants with unrecognized CKD were predominantly female (71.2% versus 47.8%; P,0.001) and older (mean age, 69.9 years versus 55.9 years; P,0.001) ( Table 5) . Participants with unrecognized CKD were more likely to have a previous diagnosis of hypertension, diabetes, or vascular disease, but were less likely to smoke compared with those with no CKD. Individuals with unrecognized CKD were also more likely to be overweight or obese, and present with heavy urine protein, hematuria, hypertension, and elevated random blood glucose.
When the 753 participants with self-reported "kidney problems" and an eGFR,60 ml/min per 1.73 m 2 were excluded, as these participants may have had known CKD, the prevalence of unrecognized CKD was 14.6% (95% CI, 13.7 to 15.7).
Discussion
In this national targeted screening program of .6000 Canadians, we found that the majority of participants reported at least one risk factor for CKD. The prevalence of unrecognized CKD in this targeted screening program (18.8%) was higher than previously published populationbased estimates (7%) (19, 20) , demonstrating that targeted screening is able to detect a higher proportion of patients with unrecognized CKD than population-based screening. We also found that individual-targeted screening identified a higher proportion of unrecognized CKD (21.9%) than community-targeted screening (14.7%), which may inform future screening strategies aiming to capture the greatest proportion of unrecognized CKD. Early recognition of CKD, as recommended by the Kidney Disease Improving Global Outcomes clinical practice guidelines (8) , provides patients with an opportunity for preventative interventions to reduce their risk of cardiovascular events and slow the progression of CKD (2, 9) . With that in mind, several countries have conducted populationbased screening programs, such as the national kidney disease mass screening program in Japan (21) , in an effort to increase early recognition of CKD and reduce the burden of ESRD. However, population-based screening programs are not cost-effective (10) . Targeted screening for CKD has shown promise. A recent systematic review found screening for CKD to be cost-effective among those at highest risk for CKD, namely patients with diabetes or hypertension (11) . Our study highlights the effectiveness of targeted screening for CKD on the basis of diabetes and hypertension, as these self-reported risk factors identified the highest proportion of unrecognized CKD within the SeeKD participant population.
The SeeKD targeted screening program is similar to the KEEP in the United States, led by the National Kidney Foundation. Although both programs recruit individuals based on their risk factors for CKD, the KEEP concentrates their efforts on black populations, while the SeeKD considered other ethnic groups (Aboriginal, Hispanic, South Asian, Asian, and African) as being a risk factor for CKD (22) . Targeting individuals from high-risk ethnic groups is not uncommon given the disproportionate burden of ESRD among different ethnic groups, and such screening programs have been established in Australia (23) and Canada (24) . Further, the KEEP used a limited number of risk factors (personal history of diabetes or hypertension, or a family history of diabetes, hypertension, or kidney disease) (12, 22, 25) compared with the SeeKD program (diabetes, hypertension, existing kidney problems, family history of kidney disease, member of high-risk ethnic population, current vascular disease, or currently using tobacco products). The use of characteristics such as smoking and a broad definition of cardiovascular disease Both the KEEP and SeeKD programs identified a higher proportion of unrecognized CKD than population-based programs in the United States (12) and Canada (19) , where prevalence rates of 13% and 7%, respectively, have been reported. When we excluded participants with self-reported kidney problems and an eGFR,60 ml/min per 1.73 m 2 , the prevalence of unrecognized CKD in the SeeKD program was 14.6%. As targeted screening aims to include all individuals at risk for CKD, and given the lack of definitive diagnosis of CKD for these participants, the SeeKD program included participants with self-reported kidney problems. Importantly we also found that individualtargeted screening, which included preselecting individuals with risk factors for CKD and often signing them up for the screening events in advance, identified an even higher proportion of patients with unrecognized CKD. Features of these screening strategies, and in particular the focus on targeting risk factors such as diabetes and hypertension, may be incorporated into future screening activities to improve the detection of patients with unrecognized CKD. The results from this study will also inform the second phase of the SeeKD program in Canada, particularly with respect to the populations being targeted.
Our results suggest that the SeeKD targeted screening program was successful in identifying a high proportion of individuals with risk factors and subsequently those with unrecognized CKD, therefore demonstrating potential as an effective method for early recognition of CKD. In fact, the majority of individuals with unrecognized CKD had category 3a CKD, emphasizing that targeted screening provides an important opportunity for early intervention to slow the progression of CKD. Consequently, these findings will inform prevalence estimates for future randomized controlled trials of screening programs. While the results demonstrate the feasibility of targeted screening for CKD, they also reveal the complexities of conducting targeted screening. The optimal strategies for targeted screening, including individual-targeted versus community-targeted, remain unknown due to the current paucity of evidence (7, 9) . Further research is required to determine the key components of a successful targeted screening program for CKD.
The SeeKD targeted screening program should be interpreted in light of its limitations. Firstly, there may be volunteer bias as participants self-selected to participate, and therefore may be systematically different from those who do not participate (26) . This is evident by the SeeKD participant characteristics, where the majority of participants were older females who indicated that they participated because of a personal concern for their health, which may limit the generalizability of the study results. The inclusion of participants with self-reported kidney problems may contribute to an overestimation of the prevalence of unrecognized CKD, although we also provide an estimate of unrecognized CKD after excluding these individuals. There is potential misclassification of CKD, as participants were considered to have unrecognized CKD (eGFR,60 ml/min per 1.73 m 2 ) on the basis of a single creatinine measurement and without using albuminuria. Finally, the StatSensor device is not calibrated to isotope dilution mass spectrometry standards and may underestimate eGFR levels (16) . This will result in overestimation of CKD, although the expectation is that diagnosis of CKD will be confirmed by an individual's health care provider. Given its performance characteristics, the StatSensor is a reasonable instrument for the purposes of screening, with confirmation of CKD diagnosis required.
The SeeKD screening program is the first national targeted screening initiative undertaken in Canada, and was able to identify a high proportion of participants at risk of CKD and a greater proportion of participants with unrecognized CKD, as compared with population-based estimates. These results highlight the importance of targeted screening for CKD, and demonstrate differences between two broad strategies for targeted screening (individual-targeted versus community-targeted screening) for CKD in Canada. This research is generalizable to the Canadian population with risk factors for CKD. Future research will evaluate the effectiveness of individual goalsetting and counseling held at the SeeKD targeted screening events for eliciting a health behavior change among participants.
